Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3335
Peer-review started: October 8, 2015
First decision: November 5, 2015
Revised: November 19, 2015
Accepted: December 19, 2015
Article in press: December 21, 2015
Published online: March 28, 2016
Processing time: 168 Days and 21.7 Hours
AIM: To investigate whether the expression of platelet-derived growth factor receptor-α-positive (PDGFRα+)-cells is altered in Hirschsprung’s disease (HD).
METHODS: HD tissue specimens (n = 10) were collected at the time of pull-through surgery, while colonic control samples were obtained at the time of colostomy closure in patients with imperforate anus (n = 10). Immunolabelling of PDGFRα+-cells was visualized using confocal microscopy to assess the distribution of these cells, while Western blot analysis was undertaken to quantify PDGFRα protein expression.
RESULTS: Confocal microscopy revealed PDGFRα+-cells within the mucosa, myenteric plexus and smooth muscle in normal controls, with a marked reduction in PDGFRα+-cells in the HD specimens. Western blotting revealed high levels of PDGFRα protein expression in normal controls, while there was a striking decrease in PDGFRα protein expression in the HD colon.
CONCLUSION: These findings suggest that the altered distribution of PDGFRα+-cells in both the aganglionic and ganglionic HD bowel may contribute to the motility dysfunction in HD.
Core tip: Hirschsprung’s disease is a congenital condition characterised by an absence of ganglia in the distal colon. Platelet-derived growth factor receptor-α-positive (PDGFRα+)-cells are a novel cell type recently found to be involved in gastrointestinal neurotransmission and smooth muscle contractility. Our study has revealed a striking decrease in PDGFRα+-cell expression in Hirschsprung’s disease colon compared to normal control colon. These results suggest an exciting new role for PDGFRα+-cells in the pathophysiology of this complex condition.